Alpha-9 Theranostics has filed a notice of an exempt offering of securities to raise $75,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Alpha-9 Theranostics is raising $75,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, David Hirsch played a key role in…